Revolution Medicines to Participate in Upcoming Investor Conferences

01.02.2024 - REDWOOD CITY, Calif., Feb. 01, 2024 (GLOBE NEWSWIRE) - Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, today announced that Mark A. Goldsmith, M.D., Ph.D., the ...

Related Keywords

Marka Goldsmith , ,Nasdaq ,Health Care Conference ,Revolution Medicines Inc ,Guggenheim Healthcare Talks ,Biotechnology Conference ,Annual Health Care ,Revolution Medicines Chart ,Evolution Medicines Kurs ,Evolution Medicines Aktie ,